Towa International at CPHI Frankfurt 2025: Driving transformative connections and global synergies

From October 28–30, Messe Frankfurt once again became the global epicenter of the pharmaceutical industry as it hosted CPHI Frankfurt 2025, the world’s leading event for pharma professionals.

For Towa, this year’s edition was especially meaningful. We proudly celebrated our 5th anniversary, a milestone that reflects our continued growth, strengthens our commitment to research and innovation, and inspires us to keep tracing the future alongside our partners worldwide.

Over the course of three dynamic days, our B2B and B2C teams joined forces with Breckenridge Pharmaceutical, our U.S. subsidiary, demonstrating how cross-functional collaboration drives meaningful impact. We were also honored to welcome a delegation from our parent company, Towa Pharmaceutical, further reinforcing our international synergies and opening new avenues for global cooperation.

More than 100 meetings took place at our stand, where conversations turned into ideas, ideas into projects, and projects into opportunities for long-term strategic partnerships. CPHI Frankfurt continues to be a powerful platform not only to strengthen relationships with customers and suppliers, but also to explore new ways of growing together.

Our stand reflected our Japanese heritage through a minimalist and elegant design inspired by contemporary Japanese aesthetics. Visitors also enjoyed traditional Japanese hospitality, including freshly prepared sushi served daily, creating a welcoming space to connect, exchange perspectives, and build lasting relationships.

Three intense and inspiring days filled with meaningful conversations, genuine smiles, and stronger collaboration than ever before. CPHI Frankfurt 2025 was more than a trade fair, it was a celebration of who we are and what we are building together.

Thank you to everyone who made it possible. We look forward to continuing this journey, together.